💹 Your Post-Notable Earnings Report (Dec 1)

Open Email...Your Morning Report Inside…Post Earnings for Major Stocks
Your Notable Earnings Report

Unsubscribe

⏳ Final hours: the $1 AI trading deal ends soon (ad)
Dear Reader,
I hope you are having a great Monday and also hope you had a great weekend! I am sending you the list of major stocks which reported Earnings a few days ago with Earnings Surprise (to help you find Post-Earnings trading and/or investing opportunities).

🤝 Partner with Elon Musk on Project Colossus… Before December 1st 🗓️ (ad)

Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you…

To partner with Elon on what he believes will be the biggest AI project of the century…

Starting with as little as $500.


👉 Click here to see how you could take a stake in Elon's private company.

Symbol CompanyEarning DateEPS Surprise %
LI11/26 before -325.00%
DE11/26 before -0.76%
ANF11/25 before 10.28%
NIO11/25 before 12.50%
NTNX11/25 before 91.67%
BURL11/25 before 13.21%
BBY11/25 before 6.87%
DKS11/25 before 6.11%
KSS11/25 before 152.63%
URBN11/25 before 7.56%
AVXL11/25 before 15.38%
WOOF11/25 before 250.00%
HPQ11/25 before 2.20%
BABA11/25 before -10.20%
ADI11/25 before 1.80%
Click Here to View Your Full Report
sun Before Market Opensun After Market Close

Four Analysts Say the Market Is Missing This Story 📊 (ad)*

A tiny biotech just posted historic clinical results — the first drug to reverse myocarditis-driven heart damage.
Presented by a Mayo Clinic leader.
Validated with 99% confidence.
And now entering a massive Phase 3 targeting a $1B+ market.

Analysts say the stock is still wildly mispriced… with an average target pointing to 700% upside.


👉 See the full breakdown while it's still under the radar.

📈 Wall Street Sees 700% Upside After New Heart Data (ad)*

A tiny biotech may be about to do for heart disease what Ozempic did for obesity.
Its therapy just became the first drug in history to reverse structural heart damage — with 99% confidence in only 12 weeks.
Now in a fully funded Phase 3 targeting a billion-dollar market dominated by a $270,000/year drug…
Wall Street sees 700% upside.


Before this breaks wide open, read the full briefing. ✅

How to use EPS Surprice in your Post-Earnings trading strategies:
Options Trading - if you are an Options trader, you can use the Ride-the-Wave strategy (to target multi-day price momentum following a company's earnings announcement) or the Price Reversal strategy (to target the reversal of next-day big price movement). Please click on Ride-the-Wave Strategy to learn more about it.
Stock Trading - If you're a stock trader/investor or portfolio manager, you may want to consider adjusting your positiosn based on a EPS surprise reported by the company.
At Daily Options Signals, we're really excited to help you trade more confidently. To that end, we're constantly developing new content to go alongside our platform insights, which will further our mission to help you become a better trader.
To your trading success,
Support Team
Daily Options Signals
PS: Daily Options Signals is morning newsletter, powered by StockEarnings proprietary technology.
URGENT: Trump's AI Policy Shift
Massive manufacturing reshoring is coming
FREE report just released → Get your copy before it's too late

(ad)* This message is a PAID ADVERTISEMENT for Cardiol Therapeutics Inc. (NASDAQ:CRDL) (TSX:CRDL) from Market Jar Media Inc. Daily Options Signals, Inc and StockEarnings, Inc has received a fixed fee of $4000 from Market Jar Media Inc for multiple Dedicated Email Sends, Newsletter Sponsorships and SMS Sends between Dec 01, 2025 and Dec 05, 2025. Other than the compensation received for this advertisement sent to subscribers, Daily Options Signals and its principals are not affiliated with either Cardiol Therapeutics Inc. (NASDAQ:CRDL) (TSX:CRDL) or Market Jar Media Inc. Daily Options Signals and StockEarnings its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither Daily Options Signals and StockEarnings nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from Daily Options Signals and StockEarnings to buy or sell any security. Daily Options Signals and StockEarnings has not evaluated the accuracy of any claims made in this advertisement. Daily Options Signals and StockEarnings recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding Cardiol Therapeutics Inc. (NASDAQ:CRDL) (TSX:CRDL) on TradingWhisperer website for additional information about the relationship between Market Jar Media Inc and Cardiol Therapeutics Inc. (NASDAQ:CRDL) (TSX:CRDL).



Daily Options Signals is a subsidiary of StockEarnings, Inc (SE). SE is a research service not owned or managed by registered brokers and therefore this site does not make any investment recommendations. The information provided in this newsletter is not guaranteed as to the accuracy or completeness. Each user of SE chooses to do trades at their sole discretion and risk. SE is not responsible for gains/losses that may result in the trading of these securities.

This newsletter includes paid advertisements. The source of all third-party content in which SE receives some sort of compensation, is clearly and prominently identified herein as "ad" or "Sponsored". Although we have sent you these advertisements, SE does not specifically endorse any third-party product nor is it responsible for the content of the advertisement or the experience with the third-party advertiser. Furthermore, we make no guarantee or warranty about what is advertised.

All investments involve risk, losses may exceed the principal invested, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Please click here for SE Disclaimers.

StockEarnings Inc

33 SE 4th St, Suite 100,

Boca Raton, FL 33432 USA | W: 877.6.STOCKS

Unsubscribe


Today's Bonus Content: Markets Are Unpredictable — This Stock Isn't 💎

Subscribe to receive free email updates:

0 Response to "💹 Your Post-Notable Earnings Report (Dec 1)"

Post a Comment